Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Pleural Neoplasms"" wg kryterium: Temat


Tytuł:
Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes.
Autorzy:
Baird A; Department of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Nasser A; Department of Oncology, Western University, London, ON N8W 2X3, Canada.
Tanuseputro P; Department of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Bruyère Research Institute, Ottawa, ON K1R 6M1, Canada.; ICES, University of Ottawa, Ottawa, ON K1Y 4E9, Canada.; Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
Webber C; Bruyère Research Institute, Ottawa, ON K1R 6M1, Canada.; ICES, University of Ottawa, Ottawa, ON K1Y 4E9, Canada.; Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
Wheatley-Price P; Department of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
Munro C; Department of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 14; Vol. 31 (2), pp. 1028-1034. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma, Malignant*/therapy
Mesothelioma*/therapy
Mesothelioma*/pathology
Pleural Neoplasms*/therapy
Pleural Neoplasms*/pathology
Humans ; Male ; Female ; Palliative Care ; Retrospective Studies ; Death
Czasopismo naukowe
Tytuł:
A Rare Presentation of Minimally Invasive Mesothelioma as a Large Tension Pneumothorax.
Autorzy:
Marshall T; Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.; Pulmonary Critical Care Division, Allegheny General Hospital, Pittsburgh, PA, USA.
Lane J; Department of Pathology, Cleveland Clinic Akron General, Akron, OH, USA.
Lahorra J; Department of Cardiothoracic Surgery, Cleveland Clinic Akron General, Akron, OH, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 109-114. Date of Electronic Publication: 2023 May 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Pneumothorax*/diagnosis
Pneumothorax*/etiology
Pneumothorax*/surgery
Mesothelioma*/complications
Mesothelioma*/diagnosis
Mesothelioma*/surgery
Mesothelioma, Malignant*/complications
Pleural Effusion*/complications
Pleural Neoplasms*/complications
Pleural Neoplasms*/diagnosis
Pleural Neoplasms*/surgery
Male ; Humans ; Aged, 80 and over ; Pleura/surgery
Czasopismo naukowe
Tytuł:
Pleural epithelioid hemangioendothelioma in a 39-Year-old female: a case report.
Autorzy:
Mardani P; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shahriarirad R; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Nekooeian M; Health and System Research center, Shiraz University of Medical Sciences, Shiraz, Iran.; Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Anbardar MH; Department of Pathology, Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaian B; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Kamran H; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Students Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ayare N; Students Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Vafabin M; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Fouladi D; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 12; Vol. 19 (1), pp. 118. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hemangioendothelioma, Epithelioid*/diagnosis
Hemangioendothelioma, Epithelioid*/pathology
Hemangioendothelioma, Epithelioid*/surgery
Pleural Neoplasms*/surgery
Pleural Effusion*/pathology
Humans ; Female ; Adult ; Pleura/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report.
Autorzy:
Zhang X; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.; Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, China.
Xu Q; Department of Medical Oncology, Qinghai Provincial People's Hospital, Xining, Qinghai, China.
Zhang Y; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.; Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Department of Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 667-671. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Case Reports
MeSH Terms:
Sarcoma, Synovial*/drug therapy
Sarcoma, Synovial*/genetics
Mediastinal Neoplasms*/drug therapy
Thymus Neoplasms*/drug therapy
Heart Neoplasms*/drug therapy
Pleural Neoplasms*/drug therapy
Indazoles*
Humans ; Adolescent ; Nivolumab/pharmacology ; Nivolumab/therapeutic use ; Pyrimidines/therapeutic use ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use ; BRCA2 Protein/genetics
Raport
Tytuł:
LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study.
Autorzy:
Arimura K; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan. .
Hiroshima K; Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Nagashima Y; Department of Surgical Pathology, Tokyo Women's Medical University, Tokyo, Japan.
Nakazawa T; Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Ogihara A; Department of Thoracic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Orimo M; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Sato Y; Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Katsura H; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Kanzaki M; Department of Thoracic Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Kondo M; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Tagaya E; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 07; Vol. 23 (1), pp. 1206. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma, Malignant*
Mesothelioma*/drug therapy
Mesothelioma*/genetics
Mesothelioma*/metabolism
Pleural Neoplasms*/drug therapy
Pleural Neoplasms*/genetics
Pleural Neoplasms*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; Female ; Retrospective Studies ; Immune Checkpoint Inhibitors ; Prognosis ; Programmed Cell Death 1 Receptor ; RNA, Messenger/genetics ; Biomarkers, Tumor/analysis
Czasopismo naukowe
Tytuł:
Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
Autorzy:
Yoshida M; Department of Diagnostic Pathology, Kobe University Hospital, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Jimbo N; Department of Diagnostic Pathology, Kobe University Hospital, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. bahn_.
Tsukamoto R; Department of Diagnostic Pathology, Kobe University Hospital, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Itoh T; Department of Diagnostic Pathology, Kobe University Hospital, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Kawahara K; Division of Pathology for Regional Communication, Kobe University Graduate School of Medicine, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Mitsui S; Division of Thoracic Surgery, Kobe University Graduate School of Medicine, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Tanaka Y; Division of Thoracic Surgery, Kobe University Graduate School of Medicine, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Maniwa Y; Division of Thoracic Surgery, Kobe University Graduate School of Medicine, Address: 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2023 Nov 28; Vol. 18 (1), pp. 126. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Mesothelioma, Malignant*
Mesothelioma*/diagnosis
Mesothelioma*/genetics
Mesothelioma*/pathology
Pleural Neoplasms*/diagnosis
Pleural Neoplasms*/genetics
Pleural Neoplasms*/pathology
Pleural Effusion*/genetics
Sarcoma*/genetics
Male ; Humans ; Aged ; In Situ Hybridization, Fluorescence ; Homozygote ; Sequence Deletion ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Ubiquitin Thiolesterase/analysis ; Ubiquitin Thiolesterase/genetics
Czasopismo naukowe
Tytuł:
En bloc resection of the recurrent pleural mesothelioma and reconstruction of the chest wall after immunotherapy: A case report.
Autorzy:
Qin C; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Xia Q; Operating Room of Anesthesia Surgery Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; West China School of Nursing, Sichuan University, Chengdu, People's Republic of China.
Chen ZJ; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zhou Q; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zheng X; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (30), pp. 3063-3066. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Case Reports
MeSH Terms:
Mesothelioma, Malignant*/pathology
Thoracic Wall*/surgery
Thoracic Wall*/pathology
Mesothelioma*/surgery
Mesothelioma*/pathology
Pleural Neoplasms*/surgery
Pleural Neoplasms*/pathology
Female ; Humans ; Adult ; Nivolumab ; Ipilimumab ; Immunotherapy
Raport
Tytuł:
A case series of malignant pericardial effusion.
Autorzy:
Hatta SSBWM; Walsall Healthcare NHS Trust.
Mirza AR; Walsall Healthcare NHS Trust.
Sunni N; Walsall Healthcare NHS Trust.
Bashir A; Walsall Healthcare NHS Trust.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2023 Nov; Vol. 23 (Suppl 6), pp. 18-19.
Typ publikacji:
Journal Article
MeSH Terms:
Pericardial Effusion*/diagnostic imaging
Pericardial Effusion*/etiology
Heart Neoplasms*
Pleural Neoplasms*
Humans
Czasopismo naukowe
Tytuł:
Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
Autorzy:
Ibnian AM; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.; Department of Internal Medicine, Yarmouk University, Irbid, Jordan.
Khan OU; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Chan R; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Bangalore Lakshminarayana U; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Kiran F; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Abed S; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Abbas R; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Amir A; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Al-Kofahi NK; Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Oct 04; Vol. 24, pp. e941263. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Mesothelioma*/diagnosis
Mesothelioma*/pathology
Pleural Neoplasms*/diagnosis
Pleural Effusion*/diagnostic imaging
Pleural Effusion*/etiology
Asbestos*
Pleural Diseases*
Male ; Humans ; Aged, 80 and over ; Pleura/pathology
Czasopismo naukowe
Tytuł:
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
Autorzy:
Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Xu C; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Wang W; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Zhang Y; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Li Z; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Song Z; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Wang J; Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yu J; Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Liu J; Department of Thoracic Cancer, Jilin Cancer Hospital, Changchun, China.
Zhang S; Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.
Cai X; Department of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Li W; Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Zhan P; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Liu H; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Miao L; Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Min L; Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, China.
Li J; Department of Radiation Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.
Liu B; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Yuan J; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
Jiang Z; Department of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Lin G; Department of Medical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.
Chen X; Department of Thoracic Surgery, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China.
Pu X; Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Rao C; Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Lv D; Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
Yu Z; Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, China.
Li X; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Tang C; Department of Medical Oncology, Peking University International Hospital, Beijing, China.
Zhou C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.
Zhang J; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Guo H; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Meng R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu X; Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, China.
Wu J; Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, China.
Hu X; Zhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, China.
Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Chen X; Department of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.
Pan W; Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, China.
Pang F; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Zhang W; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Jian Q; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Wang K; Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, China.
Wang L; Department of Oncology, Baotou Cancer Hospital, Baotou, China.
Zhu Y; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Yang G; Department of Thoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.
Lin X; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.
Cai J; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Feng H; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Wang L; Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
Du Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yao W; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Shi X; Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, China.
Niu X; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Yuan D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yao Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Huang J; Department of Oncology, Lishui Municipal Central Hospital, Lishui, China.
Wang X; Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, China.
Zhang Y; Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.
Sun P; Department of Pathology, The Second Hospital of Jilin University, Changchun, China.
Wang H; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, China.
Ye M; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Wang D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Wang Z; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Hao Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Wang Z; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Wan B; Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Lv D; Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, China.
Yu J; Department of Respiratory Medicine, Affiliated Hospital of Jiangxi University of Chinese Medicine, Jiangxi Province Hospital of Chinese Medicine, Nanchang, China.
Kang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Zhang J; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Zhang C; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Wu L; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Shi L; Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Ye L; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Wang G; Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Wang Y; Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Gao F; Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Huang J; Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, China.
Wang G; Department of Respiratory Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Wei J; Department of Pathology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, China.
Huang L; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Li B; Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Zhang Z; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China.
Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Liu Y; Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Li Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Liu Z; Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, China.
Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wu L; Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Wang Q; Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Huang W; Department of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Hong Z; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
Wang G; Institute of Respiratory Diseases, Xinjian Hospital, Third Military Medical University, Chongqing, China.
Qu F; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.
Fang M; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Fang Y; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Zhu X; Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Du K; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
Ji J; Department of Radiology, Lishui Municipal Central Hospital, Lishui, China.
Shen Y; Department of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Chen J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
Ma S; Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.
Lu Y; Department of Clinical Pathology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Liu A; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhong W; Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, China.
Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Sep; Vol. 14 (26), pp. 2715-2731. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma, Malignant*/diagnosis
Mesothelioma, Malignant*/epidemiology
Mesothelioma, Malignant*/therapy
Pleural Neoplasms*/diagnosis
Pleural Neoplasms*/epidemiology
Pleural Neoplasms*/therapy
Humans ; Consensus ; East Asian People ; China/epidemiology
Czasopismo naukowe
Tytuł:
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.
Autorzy:
Mosleh B; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Schelch K; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Mohr T; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Klikovits T; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Wagner C; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Ratzinger L; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Dong Y; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Sinn K; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Ries A; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Berger W; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Grasl-Kraupp B; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Hoetzenecker K; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Laszlo V; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Dome B; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.; National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University, Budapest, Hungary.
Hegedus B; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Jakopovic M; Department for Respiratory Diseases Jordanovac, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Hoda MA; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Grusch M; Center for Cancer Research, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Aug; Vol. 14 (22), pp. 2177-2186. Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/pathology
Mesothelioma*/genetics
Mesothelioma*/pathology
Mesothelioma, Malignant*
Pleural Neoplasms*/genetics
Pleural Neoplasms*/pathology
Humans ; Fibrosis ; Prognosis ; RNA, Messenger/genetics
Czasopismo naukowe
Tytuł:
High density and proximity of CD8 T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.
Autorzy:
Yin Y; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Sakakibara R; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Honda T; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Kirimura S; Department of Pathology, Tokyo Medical and Dental University, Tokyo, Japan.
Daroonpan P; Department of Molecular Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Kobayashi M; Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Ando K; Department of Thoracic Surgery, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Ujiie H; Department of Thoracic Surgery, Hokkaido University Hospital, Sapporo, Japan.
Kato T; Department of Thoracic Surgery, Hokkaido University Hospital, Sapporo, Japan.
Kaga K; Department of Thoracic Surgery, Hokkaido University Hospital, Sapporo, Japan.
Mitsumura T; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.; Department of Pulmonary Immunotherapeutics, Tokyo Medical and Dental University, Tokyo, Japan.
Nakano R; Department of Respiratory Medicine, Hokkaido Kin-Ikyo Chuo Hospital, Sapporo, Japan.
Sakashita H; Department of Chemotherapy, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Matsuge S; Department of Thoracic Surgery, Hokkaido Kin-Ikyo Chuo Hospital, Sapporo, Japan.
Ishibashi H; Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Akashi T; Department of Pathology, Tokyo Medical and Dental University, Tokyo, Japan.
Hida Y; Department of Thoracic Surgery, Hokkaido University Hospital, Sapporo, Japan.
Morohoshi T; Department of Thoracic Surgery, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Azuma M; Department of Molecular Immunology, Tokyo Medical and Dental University, Tokyo, Japan.
Okubo K; Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (20), pp. 1991-2000. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma, Malignant*/drug therapy
Mesothelioma*/drug therapy
Mesothelioma*/pathology
Pleural Neoplasms*/drug therapy
Pleural Neoplasms*/pathology
Humans ; Nivolumab/pharmacology ; Nivolumab/therapeutic use ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Retrospective Studies ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non-small cell lung cancer: A real-world study.
Autorzy:
Wei J; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
Shi Z; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
Song Z; Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 18211-18218. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/complications
Carcinoma, Non-Small-Cell Lung*/drug therapy
Pericardial Effusion*/etiology
Antineoplastic Agents*/therapeutic use
Lung Neoplasms*/drug therapy
Cardiac Tamponade*/complications
Cardiac Tamponade*/drug therapy
Pleural Neoplasms*/drug therapy
Humans ; Retrospective Studies ; Catheters/adverse effects ; Drainage/adverse effects
Czasopismo naukowe
Tytuł:
Strategies to reduce morbidity following pleurectomy and decortication for malignant pleural mesothelioma.
Autorzy:
Bou-Samra P; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Chang A; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Zhang K; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Azari F; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Kennedy G; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Guo E; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Hwang WT; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics (DBEI), University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Singhal S; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Sep; Vol. 14 (27), pp. 2770-2776. Date of Electronic Publication: 2023 Aug 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Mesothelioma, Malignant*
Mesothelioma*/pathology
Pleural Neoplasms*/pathology
Lung Neoplasms*/surgery
Sepsis*
Humans ; Aged ; Treatment Outcome ; Morbidity
Czasopismo naukowe
Tytuł:
Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma.
Autorzy:
Kreienbühl J; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Changkhong S; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Orlowski V; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Kirschner MB; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Opitz I; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Meerang M; Department of Thoracic Surgery, University Hospital Zürich, 8091 Zürich, Switzerland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 29; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma*/genetics
Mesothelioma, Malignant*
Pleural Neoplasms*/genetics
Humans ; Cell Survival/genetics ; Cullin Proteins/genetics ; Matrix Metalloproteinase 2 ; Transforming Growth Factor beta1/genetics ; Ubiquitin
Czasopismo naukowe
Tytuł:
Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells.
Autorzy:
Ries A; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Slany A; Department of Analytical Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Pirker C; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Mader JC; Department of Analytical Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Mejri D; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Mohr T; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.; Department of Analytical Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.; Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Waehringer Guertel 38, 1090 Vienna, Austria.; ScienceConsult-DI Thomas Mohr KG, Enzianweg 10a, 2353 Guntramsdorf, Austria.
Schelch K; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.; Department of Thoracic Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Flehberger D; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Maach N; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Hashim M; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Hoda MA; Department of Thoracic Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Dome B; Department of Thoracic Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.; National Korányi Institute of Pulmonology, Korányi Frigyes u. 1, 1122 Budapest, Hungary.; Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, Rath Gyorgy u. 7-9, 1122 Budapest, Hungary.; Department of Translational Medicine, Lund University, Sölvegatan 19, 22184 Lund, Sweden.
Krupitza G; Department of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Berger W; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Gerner C; Department of Analytical Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Holzmann K; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Grusch M; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Aug 05; Vol. 12 (15). Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Telomerase*/metabolism
Mesothelioma*/genetics
Mesothelioma, Malignant*
Pleural Neoplasms*/genetics
Humans ; Proteome/metabolism ; Fibroblasts/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Predicting survival for patients with mesothelioma: development of the PLACE prognostic model.
Autorzy:
Zhang Y; Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongtinan Rd, Chaoyang District, Beijing, 100020, China.; Department of Pulmonary and Critical Care Medicine, Beijing Hospital, Institute of Geriatric Medicine, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, 100005, China.
Li N; Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongtinan Rd, Chaoyang District, Beijing, 100020, China.
Li R; Department of Respiratory and Critical Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100005, China.
Gu Y; Department of Pathology, Beijing Chao-Yang Hospital , Capital Medical University, 8 Gongtinan Rd, Chaoyang District, Beijing, 100020, China.
Liu X; Department of Respiratory and Critical Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100005, China.
Zhang S; Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongtinan Rd, Chaoyang District, Beijing, 100020, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jul 26; Vol. 23 (1), pp. 698. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Mesothelioma, Malignant*
Pleural Neoplasms*/pathology
Mesothelioma*/pathology
Humans ; Aged ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
A rare case of Pleuropulmonary blastoma type III with Immunohistochemical Study.
Autorzy:
Sinai Khandeparkar SG; Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Kulkarni MM; Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Gogate BP; Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Dhavan CS; Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2023 Jul-Sep; Vol. 66 (3), pp. 632-635.
Typ publikacji:
Case Reports
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/pathology
Pleural Neoplasms*/diagnosis
Pulmonary Blastoma*/diagnosis
Cysts*/pathology
Humans ; Male ; Child
SCR Disease Name:
Pleuropulmonary blastoma
Raport
Tytuł:
Improvements in Systemic Therapies for Advanced Malignant Mesothelioma.
Autorzy:
Deiana C; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Fabbri F; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Tavolari S; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Palloni A; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Brandi G; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 21; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mesothelioma, Malignant*
Mesothelioma*/drug therapy
Lung Neoplasms*/pathology
Pleural Neoplasms*/drug therapy
Pleural Neoplasms*/pathology
Humans ; Immunotherapy/methods
Czasopismo naukowe
Tytuł:
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
Autorzy:
Bou-Samra P; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Chang A; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Azari F; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Kennedy G; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Segil A; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Guo E; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Marmarelis M; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Division of Hematology & Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Langer C; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Division of Hematology & Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Singhal S; University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Pennsylvania, Philadelphia, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12208-12220. Date of Electronic Publication: 2023 Apr 16.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lung Neoplasms*/epidemiology
Lung Neoplasms*/therapy
Lung Neoplasms*/diagnosis
Mesothelioma*/epidemiology
Mesothelioma*/therapy
Mesothelioma*/diagnosis
Mesothelioma, Malignant*
Pleural Neoplasms*/epidemiology
Pleural Neoplasms*/therapy
Female ; Humans ; Male ; Retrospective Studies ; Risk Factors ; Middle Aged ; Aged ; Aged, 80 and over
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies